| 000 | 01705 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515005001.0 | ||
| 264 | 0 | _c20060915 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1097/01.ju.0000181823.33224.a0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaplan, Steven A | |
| 245 | 0 | 0 |
_aTolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cDec 2005 |
||
| 300 |
_a2273-5. discussion 2275-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aCresols _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscarinic Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aPenile Erection _xdrug effects |
| 650 | 0 | 4 |
_aPhenylpropanolamine _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xcomplications |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTolterodine Tartrate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Retention _xdrug therapy |
| 650 | 0 | 4 |
_aUrination _xdrug effects |
| 700 | 1 | _aWalmsley, Konstantin | |
| 700 | 1 | _aTe, Alexis E | |
| 773 | 0 |
_tThe Journal of urology _gvol. 174 _gno. 6 _gp. 2273-5. discussion 2275-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.ju.0000181823.33224.a0 _zAvailable from publisher's website |
| 999 |
_c15905585 _d15905585 |
||